Clinical Trials Directory

Trials / Completed

CompletedNCT01700075

Physical and Chemical Study of Atherosclerosis Mechanisms

Comparative Physical and Chemical Study of the Mechanisms of Atherosclerosis With Development of Concept of Treatment and Prevention

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
97 (actual)
Sponsor
Nazarbayev University · Academic / Other
Sex
All
Age
26 Years – 70 Years
Healthy volunteers
Accepted

Summary

Study the mechanisms of atherosclerosis based on a comparative study of physical and chemical properties of lipid tissues at various localization with subsequent development of concept of treatment and prevention.

Detailed description

The chemical and physical properties of different lipids of body. The clinical part of the work is a prospective randomized comparative controlled clinical trial of patients with atherosclerotic diseases. Developed the concept of "limited biological resources" of the body based on the increase in the expenditure of energy reserves of the body, allowing a critical look at overweight. The role of overweight in the development of atheromatous fat was revealed. The positive results from the weight loss in patients with atherosclerotic disease were drawn. Developed the metabolic concept of atherosclerosis associated with evolutionary aging and conversion of lipids in hard atherosclerotic fat.

Conditions

Interventions

TypeNameDescription
DRUGConventional treatmentLipidlowering: "Atorvastatin" (Liprimar) - 40mg per day. Antihypertensive: "Diroton" (Lisinopril, Gedeon Richter Ltd) - 10mg twice per day and "Ditiazem" (calcium bloker from the benthodiazepines, Lannacher, Austria) - 90mg per day. Antihyperglycemic drugs: biguanides "Metformin" - 0.5 g two or tree times per day, or "Exenatide" - 5-10 µg per day. Anti-inflammatory: "TromboACC" (acetylsalicylate acid) up to 2 g per day and/or "Clopidogrel" (thienopyridine class antiplatelet agent) - 75mg per day.
DIETARY_SUPPLEMENTWeight loss treatmentWeight loss treatment by administering a healthy very low-calorie, low-fat vegetables and salt diet and includes an adjustment and modify eating behavior and increased physical activity.

Timeline

Start date
2009-01-01
Primary completion
2009-12-01
Completion
2011-12-01
First posted
2012-10-04
Last updated
2012-10-04

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT01700075. Inclusion in this directory is not an endorsement.